BMO Capital Initiates Coverage On Integra Lifesciences with Market Perform Rating, Announces Price Target of $19
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsInitiationPrice Target
BMO Capital analyst Vik Chopra initiates coverage on Integra Lifesciences (NASDAQ:IART) with a Market Perform rating and announces Price Target of $19.
BMO Capital analyst Vik Chopra initiates coverage on Integra Lifesciences (NASDAQ:IART) with a Market Perform rating and announces Price Target of $19.